The Access to Medicine Foundation works with a range of stakeholders from across the global health community – from pharmaceutical companies, to policymakers, to investment firms. Their diverse perspectives demonstrate how our evidence-based research and convening power have helped them strengthen their efforts in the mission to make access to essential medicines a global reality.
An interview with Robert Yates, Executive Director of Chatham House's Centre for Universal Health
“[The Index] clearly shows us what the best practices are, and also, what the opportunities to improve are for us as a company. We use these insights when we plan and implement new programs and initiatives, and simply to continuously improve what we do.”
Ina Witte
Associate Director Sustainability at Boehringer Ingelheim
An interview with Dr Zainab Shinkafi Bagudu, CEO at Medicaid Cancer Foundation
“The Access To Medicine Foundation has helped us a lot in creating the environment where the companies are compelled to increase access to their products and helps us greatly in our discussions with them.”
Joseph Saba
Chief Executive Officer at Axios International
“The insight provided by Access to Medicine [Foundation]’s reports and conversations with the leadership in the organization have helped us to understand the perspective of manufacturers and to identify the priorities, ecosystems and challenges that might deter them from engaging in supplying the markets that we are interested in.”
Ebere Okereke
CEO at Africa Public Health Foundation
“Access to Medicine Foundation provides a unique hub that really allows different voices to come together in many different ways and really deliver on healthcare impact into the future.”
